CIK 0001842952 · <br>Emerging growth company
Context Therapeutics Inc.
Sign in to watch- Ticker
- CNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863738787
- Phone
- 267-225-7416
- Business address
- 2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103
- Former names
- Context Therapeutics LLC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- SC 13G Stake Amended Statement of Ownership
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- SC 13G Stake Amended Statement of Ownership
- S-3 Offering Registration Statement
- D Other Notice of Sales of Unregistered Securities
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
Page 7 of 16 · 309 filings